CVS Health announced Friday that longtime executive David Joyner has replaced Karen Lynch as CEO, effective immediately. The ...
The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...
CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...
Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...